Loading...
XNAS
ZYXI
Market cap63mUSD
Jul 14, Last price  
2.11USD
1D
-5.80%
1Q
-4.09%
IPO
634.68%
Name

Zynex Inc

Chart & Performance

D1W1MN
P/E
21.31
P/S
0.33
EPS
0.10
Div Yield, %
Shrs. gr., 5y
-2.87%
Rev. gr., 5y
33.44%
Revenues
192m
+4.36%
2,258,8082,556,8098,048,25211,763,55818,681,24224,085,00034,148,00039,666,00021,684,00011,117,00011,641,00013,313,00023,432,00031,917,00045,472,00080,122,000130,301,000158,167,000184,322,000192,354,000
Net income
3m
-69.24%
107,956-320,3702,131,350110,9522,382,312350,0001,564,0001,553,000-7,301,000-6,199,000-2,911,00069,0007,365,0009,552,0009,492,0009,074,00017,103,00017,048,0009,732,0002,994,000
CFO
13m
-28.36%
-217,058-483,460746,863-715,1603,648,024-665,000-362,000-879,000-382,000961,000341,0001,700,0008,260,0009,408,0006,303,000818,0006,949,00013,746,00017,756,00012,721,000
Dividend
Jan 05, 20220.1 USD/sh
Earnings
Jul 23, 2025

Profile

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
IPO date
Nov 27, 2002
Employees
900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
192,354
4.36%
184,322
16.54%
158,167
21.39%
Cost of revenue
186,364
182,742
142,329
Unusual Expense (Income)
NOPBT
5,990
1,580
15,838
NOPBT Margin
3.11%
0.86%
10.01%
Operating Taxes
633
2,847
5,150
Tax Rate
10.57%
180.19%
32.52%
NOPAT
5,357
(1,267)
10,688
Net income
2,994
-69.24%
9,732
-42.91%
17,048
-0.32%
Dividends
(9)
(3)
(3,613)
Dividend yield
0.00%
0.00%
0.66%
Proceeds from repurchase of equity
(15,625)
(37,838)
(26,380)
BB yield
6.04%
9.61%
4.85%
Debt
Debt current
4,317
7,850
7,937
Long-term debt
84,764
90,806
35,355
Deferred revenue
(3,884)
Other long-term liabilities
10,000
Net debt
49,450
54,077
23,148
Cash flow
Cash from operating activities
12,721
17,756
13,746
CAPEX
(578)
(1,206)
(418)
Cash from investing activities
(578)
(966)
(418)
Cash from financing activities
(17,091)
7,645
(35,796)
FCF
18,895
572
3,446
Balance
Cash
39,631
44,579
20,144
Long term investments
Excess cash
30,013
35,363
12,236
Stockholders' equity
29,806
26,813
17,087
Invested Capital
79,726
99,409
85,202
ROIC
5.98%
10.86%
ROCE
5.47%
1.25%
15.63%
EV
Common stock shares outstanding
32,299
36,142
39,127
Price
8.01
-26.45%
10.89
-21.71%
13.91
39.52%
Market cap
258,715
-34.27%
393,586
-27.68%
544,257
26.61%
EV
308,165
447,663
567,405
EBITDA
8,891
5,800
18,965
EV/EBITDA
34.66
77.18
29.92
Interest
2,382
1,094
440
Interest/NOPBT
39.77%
69.24%
2.78%